Elder-Care Robots: A Reality Check on Companions, Therapeutics, and Indian Market Viability

The Demographic Shift and the Robot Promise

India’s demographic landscape is changing rapidly. With a growing elderly population and a shrinking workforce, the demand for elder-care solutions is outpacing the infrastructure of human caregivers. Robotics is often pitched as the solution to this gap. However, at RobotWale, we apply a strict grading system: shipping hardware takes precedence over pilot deployments, which take precedence over announcements. This evaluation focuses on three prominent categories of elder-care robotics: social engagement companions, therapeutic devices, and assistive home systems.

Social Engagement Companions: The Promise of Connection

ElliQ by Intuition Robotics

ElliQ is designed as an active companion for older adults. It is not a voice assistant like Amazon Alexa; it initiates conversation. The hardware features a screen and a speaker system, housed in a sleek, upright design. Intuition Robotics claims ElliQ uses AI to curate content, suggest photos, and facilitate video calls with family members.

Hardware Reality: The device requires a constant power connection and Wi-Fi. There are no physical actuators for mobility. The value proposition rests entirely on software engagement and privacy management. Independent reviews suggest ElliQ works well for tech-savvy seniors but can be confusing for those requiring a simpler interface.

India Availability: Intuition Robotics sells directly to consumers in the US and Europe. In India, there is no official distributor. Importing the unit involves customs duties on electronics, likely pushing the landed cost to approximately ₹1.2 lakhs to ₹1.5 lakhs. Without local service support, warranty claims become a significant risk.

Lovot by Greyparrot

Lovot represents a different philosophy. It is a small, pet-like robot that expresses emotion through movements and lights. Unlike ElliQ, Lovot does not have a screen. It relies on touch sensors and proximity detection to interact with the user.

Hardware Reality: Lovot has a battery life of approximately 8 hours. It requires a docking station. The movement is limited to walking and tilting. It does not perform physical tasks. The hardware quality is high, but the utility is strictly emotional. Shipping hardware is limited to pre-order batches in Japan and select international regions.

India Availability: Lovot is not officially available in India. Importing a unit involves complex customs classification as a toy or consumer electronics. The estimated landed cost is ₹2.5 lakhs to ₹3.5 lakhs. The lack of local repair infrastructure makes this a high-risk purchase for Indian households.

Therapeutic Robotics: Clinical Evidence and Use Cases

Paro Therapeutic Robot

Paro is a robotic seal developed by AIST in Japan. It is one of the few elder-care robots with documented clinical studies. It is designed specifically for dementia care and elderly loneliness reduction.

Spec Sheet Data: Paro weighs 2.5 kg. It responds to voice, touch, and light. It has internal sensors to detect petting and sounds. It does not require internet connectivity to function, which is a critical security advantage in care homes.

Clinical Claims: Research indicates Paro can reduce blood pressure and anxiety levels in patients. However, it is not a medical device in the same category as a pacemaker. It is a therapeutic tool. In the UK and US, it is sold as a medical device in some contexts but as a consumer product in others.

India Availability: Paro is available through specialized medical equipment suppliers in India. The unit costs approximately ₹4 lakhs to ₹6 lakhs depending on the configuration. Hospitals are the primary buyers, not individual families. The cost is often justified by government health grants or NGO funding.

Assistive Home Systems and Physical Care

While Lovot and Paro focus on emotional well-being, assistive home systems address physical limitations. Current hardware in this space includes lifting aids and mobility scooters with AI integration.

Hardware Limitations: Most "assistive" robots in the elder-care space are not humanoid. They are stationary or wheeled devices. Humanoid elder-care robots that can lift a patient or manage medication are largely in the pilot phase. There is no shipping hardware that can reliably replace a human caregiver for physical lifting tasks in a domestic Indian setting due to safety and liability concerns.

The Indian Market Reality: Cost and Serviceability

Bringing imported robotics to India involves significant friction. The GST on imported electronics is 18%. Customs duties can add another 10% to 20%. This makes the landed cost 40% to 50% higher than the US list price.

Serviceability: A robot that breaks down in a care home in Mumbai requires a technician. If the manufacturer has no office in India, the device becomes e-waste. This is a critical factor for institutional buyers.

Regulatory Hurdles: If a device claims to treat a medical condition (like dementia), it falls under CDSCO regulations. Paro often skirts this by classifying as a "non-medical therapeutic tool." Devices making medical claims must undergo rigorous testing. ElliQ does not claim medical treatment, classifying it as consumer electronics.

Economic Viability: CAPEX vs. OPEX

For Indian families, the cost of care is a primary concern. A human caregiver in India costs ₹15,000 to ₹25,000 per month. A robot costing ₹3 lakhs has a payback period of 10 to 15 years without maintenance. This makes the business case weak for individual consumers.

However, for institutional care homes, the ROI improves. If a robot reduces the need for one caregiver shift, the savings can offset the CAPEX. This is where shipping hardware finds its first market in India.

Conclusion: Shipping Hardware First

RobotWale maintains that elder-care robotics must be graded by what ships today, not what is announced for next year. ElliQ, Paro, and Lovot are shipping hardware with defined limitations. They are not human replacements. They are tools for engagement and therapeutic support.

For the Indian market, the viability depends on local service partners and regulatory clarity. Until then, these devices remain premium options for institutions or high-net-worth individuals willing to assume import risk. We advise buyers to prioritize serviceability over specs.